Related references
Note: Only part of the references are listed.Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung
Tomohiro Miyoshi et al.
CLINICAL CANCER RESEARCH (2017)
Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer
Julie George et al.
CLINICAL CANCER RESEARCH (2017)
Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas
De-Jun Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancers
Yih-Leong cc Chang et al.
ONCOTARGET (2017)
Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation
Moiz Vora et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment
Shohei Koyama et al.
CANCER RESEARCH (2016)
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
Natasha Rekhtman et al.
CLINICAL CANCER RESEARCH (2016)
Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes
Jarushka Naidoo et al.
CLINICAL LUNG CANCER (2016)
PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer
Seiichi Ikeda et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Scott J. Antonia et al.
LANCET ONCOLOGY (2016)
Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer
Yusuke Inoue et al.
ONCOTARGET (2016)
PD-L1 expression in small cell lung cancer
Takefumi Komiya et al.
EUROPEAN JOURNAL OF CANCER (2015)
PD-L1 expression in small cell neuroendocrine carcinomas
Anne M. Schultheis et al.
EUROPEAN JOURNAL OF CANCER (2015)
Significance of Programmed Cell Death-Ligand 1 Expression and its Association with Survival in Patients with Small Cell Lung Cancer
Hidenobu Ishii et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature
Eun Young Ki et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study
J. Le Treut et al.
ANNALS OF ONCOLOGY (2013)
A Prognostic Assay to Identify Patients at High Risk of Mortality Despite Small, Node-Negative Lung Tumors
Johannes R. Kratz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
Johannes R. Kratz et al.
LANCET (2012)
Large cell neuroendocrine carcinoma of the lung:: A retrospective analysis of 144 surgical cases
G Veronesi et al.
LUNG CANCER (2006)
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group
F Fossella et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
